1,3-Diphenylguanidine is used as pharmaceutical intermediate.
P.V.Shah; M.R.Sumler; Y.M.Ioannou; H.L.Fisher; L.L.Hall. Dermal absorption and disposition of 1,3-diphenylguanidine in rats. Journal of Toxicology and Environmental Health. 1985, 15,(5), 623-633.
P.V.Gushchin; M.Haukka; N.A.Bokach; V.Yu.Kukushkin. Platinum(iv)-mediated nucleophilic addition of 1,3-diphenylguanidine to propiononitrile. Russian Chemical Bulletin. 2008, 57,(10), 2125-2131.
Mentions de danger (UE): H302-H315-H319-H361-H335
Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. Suspected of damaging fertility or the unborn child. May cause respiratory irritation.
Mentions de prudence: P201-P261-P280-P305+P351+P338-P405-P501a
Obtain special instructions before use. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.